THU-055 Differential impact of proton pump inhibitors, statins, and nonselective beta-blockers on survival in different stages of chronic liver disease
Wen Gu(University Hospital Münster), Jonel Trebicka(Klinik für Schlafmedizin), Joan Clària(European Foundation for the Study of Chronic Liver Failure), Debbie L. Shawcross(King's College - North Carolina), Josune Cabello Calleja, Dávid Tornai(Beth Israel Deaconess Medical Center), Robert Schierwagen(University of Münster), Aleksander Krag(University of Southern Denmark), Rajiv Jalan(Roland Hill (United Kingdom)), Katrine Holtz Thorhauge(University of Southern Denmark), Frank Erhard Uschner(Goethe University Frankfurt), Michael Praktiknjo(University of Münster), Manimozhiyan Arumugam(University of Copenhagen), Wim Laleman(University Hospital Münster), Vicente Arroyo(European Foundation for the Study of Chronic Liver Failure), Jasmohan S. Bajaj(Virginia Commonwealth University), Pere Ginès(Hospital Clínic de Barcelona), Mária Papp(University of Debrecen), Minneke J. Coenraad(Leiden University Medical Center), Richard Moreau(Mizoram University)
Cited by 0
Related Papers
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
|Nature Biotechnology|2019|24.7k
Enterotypes of the human gut microbiome
|Nature|2011|7.6k
Richness of human gut microbiome correlates with metabolic markers
|Nature|2013|4.7k
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
|Journal of Hepatology|2018|2.8k